Medical therapy of a left-sided native valve endocarditis with neurologic sequela

References

1. ↵
   1. Chan KL,
   2. Embil J,
   3. Salehian O

   Systemic embolism in endocarditis: incidence, risk factors, clinical significance, and treatment strategies. In: Chan KL, Embil J, editors. Endocarditis: diagnosis and management. London (UK): Springer-Verlag; 2006. p. 229-240.
2. ↵
   1. Thuny F,
   2. Avierinos JF,
   3. Tribouilloy C,
   4. Giorgi R,
   5. Casalta JP,
   6. Milandre L,
   7. et al.

   (2007) Impact of cerebrovascular complications on mortality and neurologic outcome during infective endocarditis: a prospective multicentre study. Eur Heart J 28:1155–1161.

   OpenUrlCrossRefPubMedWeb of Science
3. ↵
   1. Anderson DJ,
   2. Goldstein LB,
   3. Wilkinson WE,
   4. Corey GR,
   5. Cabell CH,
   6. Sanders LL,
   7. et al.

   (2003) Stroke location, characterization, severity, and outcome in mitral vs. aortic valve endocarditis. Neurology 61:1341–1346.

   OpenUrlCrossRefPubMed
4. ↵
   1. Sonneville R,
   2. Mourvillier B,
   3. Bouadma L,
   4. Wolff M

   (2011) Management of neurological complications of infective endocarditis in ICU patients. Ann Intensive Care 1:10.

   OpenUrlCrossRefPubMed
5. ↵
   1. Cooper HA,
   2. Thompson EC,
   3. Laureno R,
   4. Fuisz A,
   5. Mark AS,
   6. Lin M,
   7. et al.

   (2009) Subclinical brain embolization in left-sided infective endocarditis: results from the evaluation by MRI of the brains of patients with left-sided intracardiac solid masses (EMBOLISM) pilot study. Circulation 120:585–591.

   OpenUrlAbstract/FREE Full Text
6. ↵
   1. Snygg-Martin U,
   2. Gustafsson L,
   3. Rosengren L,
   4. Alsiö A,
   5. Ackerholm P,
   6. Andersson R,
   7. et al.

   (2008) Cerebrovascular complications in patients with left-sided infective endocarditis are common: a prospective study using magnetic resonance imaging and neurochemical brain damage markers. Clin Infect Dis 47:23–30.

   OpenUrlCrossRefPubMedWeb of Science
7. ↵
   1. Wilson W,
   2. Taubert KA,
   3. Gewitz M,
   4. Lockhart PB,
   5. Baddour LM,
   6. Levison M,
   7. et al.

   (2007) Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 116:1736–1754.

   OpenUrlAbstract/FREE Full Text
8. ↵
   1. Lodi G,
   2. Figini L,
   3. Sardella A,
   4. Carrassi A,
   5. Del Fabbro M,
   6. Furness S

   (2012) Antibiotics to prevent complications following tooth extractions. Cochrane Database Syst Rev 11:CD003811.

   OpenUrlPubMed
9. ↵
   1. Ruttmann E,
   2. Willeit J,
   3. Ulmer H,
   4. Chevtchik O,
   5. Hofer D,
   6. Poewe W,
   7. et al.

   (2006) Neurological outcome of septic cardioembolic stroke after infective endocarditis. Stroke 37:2094–2099.

   OpenUrlAbstract/FREE Full Text
10. ↵
    1. Baker CN,
    2. Thornsberry C,
    3. Facklam RR

    (1981) Synergism, killing kinetics, and antimicrobial susceptibility of group A and B streptococci. Antimicrob Agents Chemother 19:716–725.

    OpenUrlAbstract/FREE Full Text